Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-077259

Chief Scientific Officer sold 1,780 shares at $14.14 ($25,169)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-25 Sale : show line 1 in the form 10b5-1 −1,780 $14.14 $25,169 174,844 D
Open-market sales · 1,780 sh · avg $14.14 · $25,169
Loading xslF345X05/ownership.xml…